Loading...

Nabriva Therapeutics plc

NBRV•NASDAQ
Healthcare
Biotechnology
$1.42
$0.01(0.71%)

Nabriva Therapeutics plc (NBRV) Stock Chart & Performance Analysis

Explore Nabriva Therapeutics plc’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
125.40%
5-Day Change
77.50%
1-Month Change
N/A
3-Month Change
-11.80%
6-Month Change
-20.67%
Year-to-Date (YTD) Change
-29.00%
1-Year Change
-65.96%
3-Year Change
-99.08%
5-Year Change
-99.78%
All-Time (Max) Change
-99.57%

Analyzing Nabriva Therapeutics plc (NBRV) Trends Across Multiple Time Frames

Nabriva Therapeutics plc Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Nabriva Therapeutics plc stock shows 125.40% 1-day change, indicating immediate volatility, while its 5-day change of 77.50% suggests a broader trend. Over a 1-month period, a N/A drop could signal a pullback, whereas a 3-month decline of -11.80% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -20.67% and a YTD drop of -29.00% might concern investors, but a 1-year loss of -65.96% and a 3-year drop of -99.08% could indicate resilience. The 5-year surge of -99.78% highlights weak historical growth, while the all-time return of -99.57% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;